FibroGen Stock Soars 16% In 5 Sessions: Is This The Start Of A Bullish Trend?

(VIANEWS) – FibroGen (NASDAQ: FGEN) stock prices experienced a 16.11% surge over five trading sessions, beginning from EUR1.8 and closing on Friday at EUR2.09, outperforming the broader market decline of 0.96%. This outperformance was powered by three consecutive days of gains as the NASDAQ fell below EUR15,973.17; FibroGen’s final close was at a discount of…

Read More

PAVmed And Momo On The List Of Winners And Losers Of Thursday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are PAVmed, PowerFleet, and Ontrak. Rank Financial Asset Price Change Updated (EST) 1 PAVmed (PAVMW) 0.03 105.67% 2024-03-14 03:08:05 2 PowerFleet (PWFL) 3.92 10.11% 2024-03-14 11:13:05…

Read More

FibroGen Stock Bullish Momentum With A 10.53% Rise On Tuesday

(VIANEWS) – The NASDAQ ended the session with FibroGen (FGEN) jumping 10.53% to $1.89 on Tuesday while NASDAQ rose 1.54% to $16,265.64. FibroGen’s last close was $1.71, 91.82% under its 52-week high of $20.90. About FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product…

Read More

VerifyMe And Hycroft Mining Holding Corporation On The List Of Winners And Losers Of Tuesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are VerifyMe, GDS Holdings Limited, and Rumble. Rank Financial Asset Price Change Updated (EST) 1 VerifyMe (VRME) 1.45 23.93% 2024-03-12 15:51:55 2 GDS Holdings Limited (GDS)…

Read More

Viking Therapeutics And VerifyMe On The List Of Winners And Losers Of Tuesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Viking Therapeutics, Vroom, and NASDAQ TEST STOCK. Rank Financial Asset Price Change Updated (EST) 1 Viking Therapeutics (VKTX) 86.01 123.53% 2024-02-27 15:17:38 2 Vroom (VRM)…

Read More

FibroGen Stock Was Up By 14.69% Before The Weekend

(VIANEWS) – The NASDAQ ended the session with FibroGen (FGEN) rising 14.69% to $2.73 on Friday while NASDAQ jumped 1.25% to $15,990.66. FibroGen’s last close was $2.38, 90.73% under its 52-week high of $25.68. About FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product…

Read More